Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

NCT00518687 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

8031

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcus Aureus
Bacteremia
Mediastinitis

Interventions

BIOLOGICAL: V710
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC